The plaintiffs voluntarily dismissed Breckenridge Pharmaceutical Inc. and Natco Pharma from the case. All claims against the Company in the litigation have now been dismissed.

Breckenridge is the ANDA holder and front-end marketing partner for the Pomalidomide capsules generic product in the US.

Natco's Pomalidomide capsules generic product has not yet launched in the US.